ARUM THERAPEUTICS INC BIOMEDISCIEN

ARUM THERAPEUTICS INC. (Based in South Korea)

Company Type: Manufacturer

Company Introduction:

ARUM THERAPEUTICS INC. is a clinical-stage biopharmaceutical company headquartered in South Korea. The company is dedicated to the discovery and development of innovative therapeutic drugs, primarily focusing on oncology. Utilizing its advanced drug discovery platforms and scientific expertise, ARUM THERAPEUTICS aims to address significant unmet medical needs by developing novel treatments for various types of cancer. Their operations involve extensive research and development activities, from initial drug candidate identification through preclinical studies and clinical trials, with the goal of bringing new medicines to patients worldwide. As a developer of proprietary drug products, ARUM THERAPEUTICS INC. functions as a manufacturer in the biopharmaceutical industry, creating intellectual property and the 'recipe' for future pharmaceutical products, rather than operating as a trading company that deals in products developed by others.

ARUM THERAPEUTICS INC BIOMEDISCIEN, a South Korean company, focuses on developing and commercializing innovative anti-cancer therapeutics. Their key products/programs include:

* **AT-301:** An innovative targeted therapy in Phase 1/2 clinical trials for the treatment of diverse advanced cancers. It is a highly selective and potent inhibitor of CDK7/12/16.

* **AT-501:** An Aurora A Kinase inhibitor.

* **Discovery Programs:** They also have ongoing discovery programs focused on identifying and developing novel anti-cancer targets.